Jones Trading Downgrades Impel Pharmaceuticals Inc (IMPL) to Hold, 'Going Concern Risk Overshadows Trudhesa Sales Growth'
Tweet Send to a Friend
(Updated - August 18, 2023 1:15 PM EDT)
Jones Trading analyst Sean Kim downgraded Impel Pharmaceuticals Inc (NASDAQ: IMPL) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jones Trading analyst Sean Kim downgraded Impel Pharmaceuticals Inc (NASDAQ: IMPL) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
